Amy Elazzouzi
Förmögenhet: 1 M $ per 2026-07-31
Förmögenhet: 1 M $ per 2026-07-31
Amy Elazzouzi is currently Director-Finance & Operations at Kew, Inc. and Secretary, Treasurer & Chief Accounting Officer at Aura Biosciences, Inc. Formerly, Ms. Elazzouzi was Controller at AVEO Pharmaceuticals, Inc. Education includes an MBA from Northeastern University and an undergraduate degree from Regis College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,14 % | 2026-09-01 | 143 600 ( 0,14 % ) | 1 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| AURA BIOSCIENCES, INC. | Comptroller/Controller/Revisor | 2024-10-25 |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Finansdirektör/CFO | - |
| Företag | Position | Slut |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Revisor | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis College
Regis College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån